• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型β1选择性肾上腺素能受体阻滞剂比索洛尔对冠心病患者的急性血流动力学影响

Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease.

作者信息

Steinmann E, Pfisterer M, Burkart F

出版信息

J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):1044-50. doi: 10.1097/00005344-198609000-00024.

DOI:10.1097/00005344-198609000-00024
PMID:2429078
Abstract

To assess acute hemodynamic effects of the new beta-adrenergic blocking drug bisoprolol with experimentally documented beta 1 selectivity, we studied 16 patients with stable angina and angiographically proven coronary artery disease. Simultaneous right heart catheterization and radionuclide angiocardiography were performed at rest and during exercise without treatment (control) and 2 h after 5 mg bisoprolol (6 patients) and 20 mg bisoprolol (10 patients), respectively, administered perorally. The hemodynamic profile of bisoprolol was similar to that previously described after acute beta-blockade. A negative chronotropic effect occurred after 5 mg bisoprolol at rest, but the negative inotropic changes did not reach significance, whereas cardiac index decreased and total vascular resistance increased after 20 mg bisoprolol. During exercise, negative inotropic and blood-pressure-lowering effects were present after both dosages, resulting in improved myocardial oxygen consumption as reflected by a significantly reduced rate pressure product. Because ejection fraction and pulmonary capillary wedge pressure were not significantly changed even after the 20 mg dose, bisoprolol has only mild negative inotropic effects and seems hemodynamically safe.

摘要

为评估具有实验证明的β1选择性的新型β肾上腺素能阻滞剂比索洛尔的急性血流动力学效应,我们研究了16例稳定型心绞痛且经血管造影证实患有冠状动脉疾病的患者。在静息状态下以及运动期间未治疗(对照)时,以及分别口服5mg比索洛尔(6例患者)和20mg比索洛尔(10例患者)后2小时,同时进行右心导管检查和放射性核素心血管造影。比索洛尔的血流动力学特征与先前急性β受体阻滞剂治疗后所描述的相似。静息状态下服用5mg比索洛尔后出现负性变时效应,但负性变力性变化未达到显著水平,而服用20mg比索洛尔后心脏指数降低,总血管阻力增加。运动期间,两种剂量后均出现负性变力性和降压效应,导致心率血压乘积显著降低,反映出心肌耗氧量改善。因为即使在20mg剂量后射血分数和肺毛细血管楔压也没有显著变化,比索洛尔仅具有轻度负性变力性效应,且在血流动力学上似乎是安全的。

相似文献

1
Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease.新型β1选择性肾上腺素能受体阻滞剂比索洛尔对冠心病患者的急性血流动力学影响
J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):1044-50. doi: 10.1097/00005344-198609000-00024.
2
Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.比索洛尔与美托洛尔和丁呋洛尔相比,对慢性缺血性心脏病患者静息及运动时左心室血流动力学的影响。
J Cardiovasc Pharmacol. 1986;8 Suppl 11:S78-82. doi: 10.1097/00005344-198511001-00014.
3
Haemodynamic effects of bisoprolol in patients with coronary heart disease: influence of various bisoprolol plasma concentrations.比索洛尔对冠心病患者的血流动力学影响:不同比索洛尔血药浓度的影响
J Cardiovasc Pharmacol. 1986;8 Suppl 11:S83-6. doi: 10.1097/00005344-198511001-00015.
4
Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.冠心病患者中钾通道阻滞剂替地沙米与β-肾上腺素能受体阻滞剂艾司洛尔及钙拮抗剂加洛帕米的比较。
Clin Cardiol. 1998 Jul;21(7):492-502. doi: 10.1002/clc.4960210708.
5
Effect of bisoprolol on cardiac performance in coronary heart disease.比索洛尔对冠心病心脏功能的影响。
Eur J Clin Pharmacol. 1989;36(3):217-22. doi: 10.1007/BF00558150.
6
Bisoprolol: a new beta-adrenoceptor blocking drug.比索洛尔:一种新型β-肾上腺素能受体阻滞剂。
Eur Heart J. 1987 Dec;8 Suppl M:121-9. doi: 10.1093/eurheartj/8.suppl_m.121.
7
Hemodynamic evaluation of bisoprolol after coronary artery surgery in patients with altered left ventricular function.左心室功能改变患者冠状动脉搭桥术后比索洛尔的血流动力学评估
Cardiovasc Drugs Ther. 1991 Jun;5(3):629-33. doi: 10.1007/BF03029731.
8
Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.比索洛尔、硝苯地平及其联合用药对心绞痛患者血流动力学和运动耐量的影响
J Cardiovasc Pharmacol. 1990;16 Suppl 5:S201-7.
9
High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.比索洛尔的突出特性是高β1选择性和良好的药代动力学。
J Cardiovasc Pharmacol. 1986;8 Suppl 11:S2-15. doi: 10.1097/00005344-198511001-00002.
10
Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.依帕诺洛尔对冠心病患者的急性全身及抗缺血作用
Cardiovasc Drugs Ther. 1994 Apr;8(2):211-9. doi: 10.1007/BF00877329.

引用本文的文献

1
Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension.比索洛尔治疗血压控制不佳患者后的血流动力学时间变化
Ann Transl Med. 2021 Jun;9(11):923. doi: 10.21037/atm-21-1796.
2
Effects of beta-blockers on archery performance, body sway and aiming behaviour.β受体阻滞剂对射箭表现、身体晃动及瞄准行为的影响。
BMJ Open Sport Exerc Med. 2021 May 7;7(2):e001071. doi: 10.1136/bmjsem-2021-001071. eCollection 2021.
3
Effect of bisoprolol on cardiac performance in coronary heart disease.比索洛尔对冠心病心脏功能的影响。
Eur J Clin Pharmacol. 1989;36(3):217-22. doi: 10.1007/BF00558150.
4
Hemodynamic evaluation of bisoprolol after coronary artery surgery in patients with altered left ventricular function.左心室功能改变患者冠状动脉搭桥术后比索洛尔的血流动力学评估
Cardiovasc Drugs Ther. 1991 Jun;5(3):629-33. doi: 10.1007/BF03029731.